New Medications

Aspirin and clopidogrel are known to reduce early recurrence of stroke, but the benefits do not last. A new study aimed to determine the efficacy and safety of cilostazol dual therapy with cilostazol for...

Erenumap, approved by the FDA for the preventive treatment of mig

There are currently no FDA-approved therapeutics for treating NAFLD, but many options are on the horizon. Steven Grinspoon, MD, discussed the options in this session.

In a new study, researchers tested the effectiveness of a monoclonal antibody in reducing monthly migraine days among patients with episodic migraine.

Delafloxacin is non-inferior to vancomycin plus aztreonam for treating acute bacterial skin and skin-structure infections